|

RTX001 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Resolution Therapeutics Limited1

Indications

  • Steatotic Liver Disease1
  • Fibrosis and Cirrhosis of Liver1
  • Cirrhosis, Decompensated1
  • Decompensated Liver Cirrhosis1
  • End-stage Liver Disease (ESLD)1

Other1 trial

RTX001 Autologous Engineered Macrophages for Liver Cirrhosis
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.